Financials
- Financial year
- 2025
- Total assets
- €430,367
- Profit
- €20,970
- Solvency
- 97.7%
Total assets▼ 30.3%
Net result
20192025
DR. PEETERS I.
ActiveSummary
DR. PEETERS I. has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €420,304 and a net result of €20,970. Equity is shrinking by about 3.8% per year across the filed financial years. Its solvency ranks better than 95% of 20,461 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
1 site
Size
€430,367total assets 2025
- Equity
- €420,304
- Profit
- €20,970
Turnover not published (micro format)
Structure
Accounts 128 days early0 of 4 deeds read
Why 93raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 59.40, cash €115,224, halvedFigures for financial year 2025 (filed 24-12-2025)Show the evidence
Checked score
Score 2025
93
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 48% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 97.7% of total assets
Liquidity
83-12
short-term debt 1.6% · cash 26.8%
Profitability
75-9
return on assets 4.9%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: < 0.1%
12-2024: < 0.1%● unchanged vs 11-2024
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025lowest value
08-2025: < 0.1%● unchanged vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025highest value
02-2026: < 0.1%● unchanged vs 01-2026highest value
03-2026: < 0.1%● unchanged vs 02-2026highest value
04-2026: < 0.1%● unchanged vs 03-2026highest value
05-2026: < 0.1%● unchanged vs 04-2026highest value
06-2026: < 0.1%● unchanged vs 05-2026highest value
07-2026: < 0.1%● unchanged vs 06-2026highest value
08-2026: < 0.1%● unchanged vs 07-2026highest value
09-2026: < 0.1%● unchanged vs 08-2026highest value
10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity ample (current ratio 59.4, compared with 5.33 in 2024; short-term debt: 1.6% and cash: 26.8% of total assets), and 2.3% of the assets are financed with debt.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 66% on liquidity, 19% on profitability and 24% on growth.
The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 23-12-2025, 128 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
128 days early
2024
138 days early
2023
2 days late
2022
17 days early
2021
37 days early
2020
24 days early
2019
2 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 49 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 24 March (4 of the last 5 filed years within 91 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
30-09-2026 year end09-10-2026 today30-04-2027 deadline
- Annual accounts filedfinancial year 2025 · micro…
- Weakest financial yearnet €20,970 ▼72.2%
- Liquidity more than 11 timescurrent ratio 59.40
Key points
By topic
Timeline
- Events
- 23
- Since
- 2009
- Next accounts
- by 30-04-2027
- 13-12-2024Annual accounts filed
- 02-05-2024Annual accounts filed
- 30-09-2023Liquidity more than triples
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Specialist medical practiceNACE 86220
- Founded
- 28-01-2008
- Year ends
- 30-09
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.